Back to GetFilings.com



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004            

OR            

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________            

Commission File Number  1-7007


BANDAG, INCORPORATED

(Exact name of registrant as specified in its charter)

Iowa


42-0802143

(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

2905 North Highway 61, Muscatine, Iowa


52761-5886

(Address of principal executive offices) (Zip Code)

(563) 262-1400

(Registrant's telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes  |X|     No  |_|

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).     Yes  |X|     No  |_|

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $1 par value; 9,119,464 shares as of April 30, 2004.
Class A Common Stock, $1 par value, 9,373,206 shares as of April 30, 2004.
Class B Common Stock, $1 par value; 918,688 shares as of April 30, 2004.


BANDAG, INCORPORATED AND SUBSIDIARIES

INDEX

Page
Part I.   FINANCIAL INFORMATION
 
Item 1. Financial Statements (Unaudited)
 
Condensed consolidated balance sheets   —
March 31, 2004 and December 31, 2003 3
 
Condensed consolidated statement of operations
Three months ended March 31, 2004 and 2003 4
 
Condensed consolidated statements of cash flows
Three months ended March 31, 2004 and 2003 5
 
Notes to condensed consolidated financial statements
March 31, 2004 6
 
Item 2.

Management's Discussion and Analysis of Financial
   Condition and Results of Operations
12
 
Item 3. Quantitative and Qualitative Disclosures about Market Risk 17
 
Item 4. Controls and Procedures 17
 
Part II.   OTHER INFORMATION
 
Item 2.

Changes in Securities, Use of Proceeds and Issuer Purchases
   of Equity Securities
18
 
Item 6. Exhibits and Reports on Form 8-K 19
 
SIGNATURES 20






2


PART I. FINANCIAL INFORMATION

BANDAG, INCORPORATED AND SUBSIDIARIES

Item 1.  Financial Statements
Condensed Consolidated Balance Sheets

In thousands, except per share data

(Unaudited)
March 31,
2004

December 31,
2003

Assets            
Current assets   
  Cash and cash equivalents   $ 159,161   $ 189,976  
  Investments    7,412    10,808  
  Accounts receivable, net    125,112    156,894  
  Inventories  
     Finished products    50,968    50,112  
     Material and work in process    13,887    12,653  


     64,855    62,765  
  Other current assets    54,613    45,843  


      Total current assets     411,153    466,286  

Property, plant, and equipment
    505,919    465,994  
Less accumulated depreciation and amortization    (359,258 )  (358,019 )


     146,661    107,975  

Intangible assets, net
    23,552    10,131  
Other assets    85,991    76,137  


        Total assets    $ 667,357   $ 660,529  


Liabilities and shareholders' equity   
Current liabilities   
  Accounts payable   $ 29,696   $ 25,710  
  Accrued employee compensation and benefits    34,122    36,978  
  Accrued marketing expenses    25,869    31,845  
  Other accrued expenses    30,012    28,462  
  Income taxes payable    14,813    14,946  
  Short-term notes payable and current portion of other obligations    10,673    10,252  


      Total current liabilities     145,185    148,193  

Long-term debt and other obligations
    38,929    35,259  
Minority interest    2,121    --  
Shareholders' equity   
  Common stock; $1.00 par value; authorized - 21,500,000 shares;  
     issued and outstanding - 9,120,403 shares in 2004;  
     9,099,745 shares in 2003    9,120    9,100  
  Class A common stock; $1.00 par value; authorized - 50,000,000 shares;  
     issued and outstanding - 9,365,019 shares in 2004;  
     9,249,756 shares in 2003    9,365    9,250  
  Class B common stock; $1.00 par value; authorized - 8,500,000 shares;  
     issued and outstanding - 918,688 shares in 2004;  
     918,688 shares in 2003    919    919  
  Additional paid-in capital    22,945    17,903  
  Retained earnings    475,181    477,499  
  Accumulated other comprehensive loss    (36,408 )  (37,594 )


      Total shareholders' equity     481,122    477,077  


        Total liabilities and shareholders' equity    $ 667,357   $ 660,529  



See notes to condensed consolidated financial statements.

3


BANDAG, INCORPORATED AND SUBSIDIARIES

Unaudited Condensed Consolidated Statements of Earnings

Three Months Ended
March 31,
In thousands, except per share data

2004
2003
           
Income            
Net sales   $ 173,529   $ 175,279  
Other    1,762    1,844  


     175,291    177,123  

Costs and expenses
  
Cost of products sold    112,803    115,331  
Engineering, selling, administrative, and other expenses    56,556    58,608  


     169,359    173,939  

Income from operations
    5,932    3,184  
Interest income    1,050    1,156  
Interest expense    (562 )  (659 )


Earnings before income taxes and minority interest    6,420    3,681  
Income taxes    2,343    1,288  
Minority interest    58    --  


Net earnings   $ 4,019   $ 2,393  



Earnings per share
  
  Basic   $ 0.21   $ 0.13  
  Diluted   $ 0.20   $ 0.12  

Comprehensive net earnings
   $ 5,205   $ 5,113  
Cash dividends per share   $ 0.325   $ 0.320  
Depreciation included in expense   $ 5,610   $ 6,961  
Weighted average shares outstanding:  
  Basic    19,250    19,118  
  Diluted    19,655    19,277  


See notes to condensed consolidated financial statements.







4


BANDAG, INCORPORATED AND SUBSIDIARIES

Unaudited Condensed Consolidated Statements of Cash Flows

Three Months Ended
March 31,
In thousands

2004
2003
           
Operating Activities            
  Net earnings   $ 4,019   $ 2,393  
  Provision for depreciation and amortization    5,845    7,200  
  Decrease in operating assets and liabilities, net    21,296    10,482  


      Net cash provided by operating activities    31,160    20,075  

Investing Activities
  
  Additions to property, plant, and equipment    (6,446 )  (4,520 )
  Purchases of investments    (4,420 )  (3,000 )
  Maturities of investments    7,816    6,043  
  Divestitures of businesses    862    3,867  
  Acquisitions of business    (52,959 )  --  


      Net cash provided by (used in) investing activities    (55,147 )  2,390  

Financing Activities
  
  Principal payments on short-term notes payable and long-term obligations    (758 )  (21 )
  Cash dividends    (6,260 )  (6,128 )
  Purchases of Common Stock, Class A Common Stock and Class B Common Stock    (33 )  (33 )


      Net cash used in financing activities    (7,051 )  (6,182 )

Effect of exchange rate changes on cash and cash equivalents
    223    1,144  


  Increase (decrease) in cash and cash equivalents    (30,815 )  17,427  
Cash and cash equivalents at beginning of period    189,976    129,412  


      Cash and cash equivalents at end of period   $ 159,161   $ 146,839  




See notes to condensed consolidated financial statements.







5


BANDAG, INCORPORATED AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements – Unaudited


Note 1.   Basis of Presentation

The condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2003.


Note 2.   Comprehensive Net Earnings

Comprehensive net earnings for the three month period ended March 31 were as follows (in thousands):

Three Months Ended
March 31,

2004
2003
Net earnings     $ 4,019   $ 2,393  
Other comprehensive income:  
   Foreign currency translation    1,186    2,720  


Comprehensive net earnings   $ 5,205   $ 5,113  








6


BANDAG, INCORPORATED AND SUBSIDIARIES


Note 3.   Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

Three Months Ended
March 31,

2004
2003
Numerator:            
  Net earnings   $ 4,019   $ 2,393  


Denominator:  
  Weighted-average shares - Basic    19,250    19,118  

  Effect of dilutive:
  
    Restricted stock    76    57  
    Stock options    329    102  


     405    159  

Weighted-average shares - Diluted
    19,655    19,277  


Earnings per share  
    Basic   $ 0.21   $ 0.13  


    Diluted   $ 0.20   $ 0.12  




Note 4.   Retirement Benefit Plans

Net periodic (benefit) cost for the three month period ended March 31 is composed of the following (in thousands):

Three Months Ended
March 31,
Pension Benefits

Three Months Ended
March 31,
Postretirement Benefits

2004
2003
2004
2003
Service cost     $ 1,058   $ 985   $ 56   $ 44  
Interest cost    1,709    1,607    98    96  
Expected return on plan assets    (1,813 )  (1,567 )  --    --  
Amortization of prior service cost    30    31    1    --  
Amortization of transitional assets    (161 )  (163 )  --    --  
Recognized actuarial (gain) loss    298    378    (13 )  (32 )




Net periodic (benefit) cost   $ 1,121   $ 1,271   $ 142   $ 108  




On December 8, 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 was enacted. For further information, refer to the footnotes of the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2003.

7


BANDAG, INCORPORATED AND SUBSIDIARIES


Note 5.   Non-Recurring Charges

During the fourth quarter of 2001, the Company recorded a non-recurring charge totaling $4,300,000 ($2,580,000 net of tax benefits) related to the closure of a North American tread rubber manufacturing facility and certain retirement benefits. Costs included $2,659,000 ($1,595,000 net of tax benefits) for termination benefits for the reduction of 46 employees, $1,521,000 ($913,000 net of tax benefits) for early retirement benefits of 19 employees, and other miscellaneous closure costs. The Company paid $93,000 and $1,321,000 in 2003 and 2002, respectively, related to the termination of employees. In the year-to-date period ended March 31, 2004, the Company paid $5,000 relating to the termination of employees. As of March 31, 2004, $1,339,000 of the charges related to the closure of the North American tread rubber manufacturing facility remained accrued. The Company estimates that substantially all of the remaining payments will be made by the end of 2004.


Note 6.   Restructuring Charges

In 2002, the Company recorded restructuring charges totaling $3,500,000 ($2,450,000 net of tax benefits) for termination benefits covering 39 employees. The Company paid approximately $2,428,000 and $650,000 in 2003 and 2002, respectively, related to the termination of employees. In the year-to-date period ended March 31, 2004, the Company paid approximately $328,000 relating to the termination of employees. As of March 31, 2004, $540,000 of the charges related to the restructuring remained accrued, which reflects a $446,000 increase in the original provision due to exchange rate changes. Substantially all of the remaining payments, which are primarily severance pay, will be made by the end of 2006.


Note 7.   Acquisition

On February 13, 2004, the Company acquired an 87.5% majority interest in Speedco, Inc. from its founders and Equilon Enterprises, LLC, a Royal Dutch Shell Group company. Speedco provides quick-service truck lubrication nationwide through 26 company-owned and six licensed on-highway locations. In total, Bandag paid approximately $53,000,000 for its 87.5% interest and to assume and retire $20,100,000 of debt. The Company anticipates recording approximately $8,000,000 of goodwill and $12,500,000 of other intangible assets; however, the purchase price allocation is still being finalized pending a final asset valuation. Speedco generated unaudited revenues of approximately $46,000,000 and unaudited pre-tax income of approximately $4,800,000 in 2003. Included in the purchase agreement is the option for Bandag to purchase the six facilities operated by the licensees.


Note 8.   Divestitures

Bandag’s TDS subsidiary sold 3 locations during the first quarter of 2004 with a net carrying value of $1,434,000 for cash of $862,000 and assumed liabilities of $374,000. The assets of these locations consisted primarily of inventory and property, plant and equipment. The divestitures resulted in a loss before income taxes and minority interest of $198,000 for the year-to-date period ended March 31, 2004.

The TDS locations divested and closed during 2004 had net sales and earnings (loss) before income taxes and minority interest as follows (in thousands):

Three Months Ended
March 31,